|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Parkin DM and Steliarova-Foucher
E: Estimates of cancer incidence and mortality in Europe in 2008.
Eur J Cancer. 46:765–781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kakar S, Grenert JP, Paradis V, Pote N,
Jakate S and Ferrell LD: Hepatocellular carcinoma arising in
adenoma: Similar immunohistochemical and cytogenetic features in
adenoma and hepatocellular carcinoma portions of the tumor. Mod
Pathol. 27:1499–1509. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mlynarsky L, Menachem Y and Shibolet O:
Treatment of hepatocellular carcinoma: Steps forward but still a
long way to go. World J Hepatol. 7:566–574. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bialecki ES and Di Bisceglie AM: Diagnosis
of hepatocellular carcinoma. HPB (Oxford). 7:26–34. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jonas S and Izaurralde E: Towards a
molecular understanding of microRNA-mediated gene silencing. Nat
Rev Genet. 16:421–433. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang XH, Wang Q, Chen JS, Fu XH, Chen XL,
Chen LZ, Li W, Bi J, Zhang LJ, Fu Q, et al: Bead-based microarray
analysis of microRNA expression in hepatocellular carcinoma:
MiR-338 is downregulated. Hepatol Res. 39:786–794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC,
Huang CH, Lee YS, Yen TC and Hsieh SY: MicroRNA-214 downregulation
contributes to tumor angiogenesis by inducing secretion of the
hepatoma-derived growth factor in human hepatoma. J Hepatol.
57:584–591. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang P, Li QJ, Feng Y, Zhang Y, Markowitz
GJ, Ning S, Deng Y, Zhao J, Jiang S, Yuan Y, et al:
TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment
promotes venous metastases of HBV-positive hepatocellular
carcinoma. Cancer Cell. 22:291–303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou K, Luo X, Wang Y, Cao D and Sun G:
MicroRNA-30a suppresses tumor progression by blocking
Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma.
Biomed Pharmacother. 93:1025–1032. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J,
Li L, Bao H, Yang L and Tu K: MicroRNA-1296 inhibits metastasis and
epithelial-mesenchymal transition of hepatocellular carcinoma by
targeting SRPK1-mediated PI3K/AKT pathway. Mol Cancer. 16:1032017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu Y, Ge K, Lu J, Huang J, Wei W and Huang
Q: MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis
through down-regulation of anthrax toxin receptor 1 (ANTXR1) and
R-Spondin 2 (RSPO2). Biomed Pharmacother. 93:334–343. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Luo X, Yang S, Zhou C, Pan F, Li Q and Ma
S: MicroRNA-328 enhances cellular motility through
posttranscriptional regulation of PTPRJ in human hepatocellular
carcinoma. Onco Targets Ther. 8:3159–3167. 2015.PubMed/NCBI
|
|
18
|
Yu L, Gong X, Sun L, Yao H, Lu B and Zhu
L: miR-454 functions as an oncogene by inhibiting CHD5 in
hepatocellular carcinoma. Oncotarget. 6:39225–39234. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xue H, Guo X, Han X, Yan S, Zhang J, Xu S,
Li T, Guo X, Zhang P, Gao X, et al: MicroRNA-584-3p, a novel tumor
suppressor and prognostic marker, reduces the migration and
invasion of human glioma cells by targeting hypoxia-induced ROCK1.
Oncotarget. 7:4785–4805. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiang X, Mei H, Qu H, Zhao X, Li D, Song
H, Jiao W, Pu J, Huang K, Zheng L and Tong Q: miRNA-584-5p exerts
tumor suppressive functions in human neuroblastoma through
repressing transcription of matrix metalloproteinase 14. Biochim
Biophys Acta. 1852:1743–1754. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng L, Chen Y, Ye L, Jiao W, Song H, Mei
H, Li D, Yang F, Li H, Huang K and Tong Q: miRNA-584-3p inhibits
gastric cancer progression by repressing Yin Yang 1-facilitated
MMP-14 expression. Sci Rep. 7:89672017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang ZF, Ho DW, Lam CT, Luk JM, Lum CT, Yu
WC, Poon RT and Fan ST: Identification of brain-derived
neurotrophic factor as a novel functional protein in hepatocellular
carcinoma. Cancer Res. 65:219–225. 2005.PubMed/NCBI
|
|
24
|
Guo D, Sun W, Zhu L, Zhang H, Hou X, Liang
J, Jiang X and Liu C: Knockdown of BDNF suppressed invasion of
HepG2 and HCCLM3 cells, a mechanism associated with inactivation of
RhoA or Rac1 and actin skeleton disorganization. APMIS.
120:469–476. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang L, Tu Y, He W, Peng Y and Qiu Z: A
novel mechanism of hepatocellular carcinoma cell apoptosis induced
by lupeol via Brain-Derived Neurotrophic Factor Inhibition and
Glycogen Synthase Kinase 3 beta reactivation. Eur J Pharmacol.
762:55–62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Long J, Jiang C, Liu B, Fang S and Kuang
M: MicroRNA-15a-5p suppresses cancer proliferation and division in
human hepatocellular carcinoma by targeting BDNF. Tumour Biol.
37:5821–5828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hayes CN and Chayama K: MicroRNAs as
biomarkers for liver disease and hepatocellular carcinoma. Int J
Mol Sci. 17:2802016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fiorino S, Bacchi-Reggiani ML, Visani M,
Acquaviva G, Fornelli A, Masetti M, Tura A, Grizzi F, Zanello M,
Mastrangelo L, et al: MicroRNAs as possible biomarkers for
diagnosis and prognosis of hepatitis B- and
C-related-hepatocellular-carcinoma. World J Gastroenterol.
22:3907–3936. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mao B and Wang G: MicroRNAs involved with
hepatocellular carcinoma (Review). Oncol Rep. 34:2811–2820. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang XP, Deng XL and Li LY: MicroRNA-584
functions as a tumor suppressor and targets PTTG1IP in glioma. Int
J Clin Exp Pathol. 7:8573–8582. 2014.PubMed/NCBI
|
|
31
|
Ueno K, Hirata H, Shahryari V, Chen Y,
Zaman MS, Singh K, Tabatabai ZL, Hinoda Y and Dahiya R: Tumour
suppressor microRNA-584 directly targets oncogene Rock-1 and
decreases invasion ability in human clear cell renal cell
carcinoma. Br J Cancer. 104:308–315. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiang J, Wu Y, Li DS, Wang ZY, Shen Q, Sun
TQ, Guan Q and Wang YJ: miR-584 suppresses invasion and cell
migration of thyroid carcinoma by regulating the target oncogene
ROCK1. Oncol Res Treat. 38:436–440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu S, Zhang J, Xue H, Guo X, Han X, Li T,
Guo X, Gao X, Liu Q and Li G: MicroRNA-584-3p reduces the
vasculogenic mimicry of human glioma cells by regulating
hypoxia-induced ROCK1 dependent stress fiber formation. Neoplasma.
64:13–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Q, Li Z, Wei S, Wang W, Chen Z, Zhang
L, Chen L, Li B, Sun G, Xu J, et al: Overexpression of miR-584-5p
inhibits proliferation and induces apoptosis by targeting WW
domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
J Exp Clin Cancer Res. 36:592017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Orlandella FM, Di Maro G, Ugolini C,
Basolo F and Salvatore G: TWIST1/miR-584/TUSC2 pathway induces
resistance to apoptosis in thyroid cancer cells. Oncotarget.
7:70575–70588. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Barde YA, Edgar D and Thoenen H:
Purification of a new neurotrophic factor from mammalian brain.
EMBO J. 1:549–553. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Choi B, Lee EJ, Shin MK, Park YS, Ryu MH,
Kim SM, Kim EY, Lee HK and Chang EJ: Upregulation of brain-derived
neurotrophic factor in advanced gastric cancer contributes to bone
metastatic osteolysis by inducing long pentraxin 3. Oncotarget.
7:55506–55517. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Au CW, Siu MK, Liao X, Wong ES, Ngan HY,
Tam KF, Chan DC, Chan QK and Cheung AN: Tyrosine kinase B receptor
and BDNF expression in ovarian cancers-Effect on cell migration,
angiogenesis and clinical outcome. Cancer Lett. 281:151–161. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang X, Martin TA and Jiang WG: Biological
influence of brain-derived neurotrophic factor on breast cancer
cells. Int J Oncol. 41:1541–1546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Radin DP and Patel P: BDNF: An oncogene or
tumor suppressor? Anticancer Res. 37:3983–3990. 2017.PubMed/NCBI
|
|
42
|
Tayyab M, Shahi MH, Farheen S, Mariyath
MPM, Khanam N, Castresana JS and Hossain MM: Sonic hedgehog, Wnt,
and brain-derived neurotrophic factor cell signaling pathway
crosstalk: Potential therapy for depression. J Neurosci Res.
96:53–62. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tajbakhsh A, Mokhtari-Zaer A, Rezaee M,
Afzaljavan F, Rivandi M, Hassanian SM, Ferns GA, Pasdar A and Avan
A: Therapeutic potentials of BDNF/TrkB in breast cancer; Current
status and perspectives. J Cell Biochem. 118:2502–2515. 2017.
View Article : Google Scholar : PubMed/NCBI
|
